Infectious diseases, including tuberculosis, malaria, and sepsis, continue to kill millions of people each year [1].

These pathogens cause severe economic hardship and systemic poverty, making the fight against them a critical priority for global health stability.

Tuberculosis is described as the world’s deadliest infectious disease, with recent cases rising in the United Kingdom [3]. In the U.S., tuberculosis clusters have been discovered at schools in California during 2023 and 2024 [5].

Other pathogens have left deep scars on human history. Smallpox once ranked among the world's deadliest illnesses, causing death in 30% of cases [1]. While smallpox is now managed, the historical impact of other diseases remains a benchmark for virulence. The Black Death decimated approximately one-third of Europe’s population during the Middle Ages [4].

Health experts said that high mortality rates are driven by the inherent virulence of these pathogens and limited access to treatment [1, 2, 4]. These diseases do not affect regions equally; they span the globe from Morocco to Asia and Europe [3, 5, 4].

“Tuberculosis is the world’s deadliest infectious disease, with cases rising in the UK,” a Yahoo News (Canada) article said [3]. This trend highlights the persistent threat of infectious agents even in developed nations.

“Smallpox used to be one of the world’s deadliest illnesses, causing death in 30% of cases,” a Yahoo Finance article said [1]. Such statistics illustrate the scale of loss before the advent of modern vaccines.

“The Black Death decimated a third of Europe’s population during the Middle Ages,” a National Geographic article said [4]. This historical event serves as a reminder of how rapidly a pathogen can reshape a continent's demographics.

“Infectious diseases, including tuberculosis, malaria, and sepsis, continue to kill millions of people each year.”

The persistence of these diseases suggests that medical advancements alone cannot eliminate global health threats. The emergence of tuberculosis clusters in U.S. schools and rising cases in the UK indicates that infectious diseases remain a dynamic threat regardless of a nation's wealth. Reducing mortality requires a combination of pharmaceutical intervention and improved infrastructure to ensure treatment reaches the most vulnerable populations.